CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Droleptan +3 moredrug
Likely dose
Droleptan 1.25 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03677323
NCT03677323N/ACompleted

Evaluation of the Efficacy of VR on Pain and Anxiety When Performing an Ultrasound-controlled Ankle Block.

Clinique Saint Jean, France·interventional·Posted Sep 19, 2018·Updated Mar 26, 2019

In Brief

A clinical study evaluating Virtual reality, Droleptan, and 2 other interventions for Hallux Valgus and Surgery. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The purpose of this study is to observe or not a reduction on pain and anxiety felt by the patient when performing an ultrasound-controlled ankle block in preparation for forefoot surgery, using a virtual reality device instead of drug sedation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedSep 19, 2018
Enrollment StartJan 2, 2019
Primary CompletionFeb 21, 2019
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 7.8 years ago

Interventions

Virtual realitydevice

The patient will have the choice between different environments and the use of this device will remain under the control of the medical team. The patient will wear the virtual reality device at the time of the completion of the ankle block and will remove it once the nerve puncture is complete.

Droleptandrug

Venous administration of 1.25 mg of Droleptan

Propofoldrug

Venous administration of 20 mg of Propofol

Sufentanyldrug

Venous administration of 5 μg of Sufentanyl.